PriceTargets.com logo

SBC Medical Group - SBC Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $8.50
  • Forecasted Upside: 60.98%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$5.28 As of 10/30/2026 05:00 PM ET
▼ -0.41 (-7.21%)

This chart shows the closing price for SBC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New SBC Medical Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SBC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SBC

Analyst Price Target is $8.50
▲ +60.98% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for SBC Medical Group in the last 3 months. The average price target is $8.50, with a high forecast of $9.00 and a low forecast of $8.00. The average price target represents a 60.98% upside from the last price of $5.28.

This chart shows the closing price for SBC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Moderate Buy

The current consensus among 3 investment analysts is to moderate buy stock in SBC Medical Group. This rating has held steady since September 2026, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/9/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/7/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
11/5/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
2/3/2026
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
5/4/2026
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
8/2/2026
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/1/2026
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/31/2026

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/9/2026Weiss RatingsUpgradeHold (C-) ➝ Hold (C)
9/22/2026Weiss RatingsUpgradeSell (D+) ➝ Hold (C-)
8/19/2026Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
8/13/2026BTIG ResearchReiterated RatingBuy ➝ Buy$8.00
5/22/2026Weiss RatingsDowngradeHold (C-) ➝ Sell (D+)
5/8/2026Weiss RatingsUpgradeSell (D+) ➝ Hold (C-)
3/27/2026Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
3/6/2026BTIG ResearchInitiated CoverageBuy$8.00
12/29/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
12/22/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
12/15/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
12/8/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
12/1/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
11/24/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
11/17/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
11/5/2025Weiss RatingsReiterated RatingSell (D) ➝ Sell (D)
11/5/2025Maxim GroupInitiated CoverageBuy$9.00
11/5/2025Maxim GroupInitiated CoverageBuy
10/14/2025Weiss RatingsReiterated RatingSell (D+) ➝ Sell (D+)
9/27/2025Weiss RatingsReiterated RatingSell (D) ➝ Sell (D)
(Data available from 10/31/2021 forward)

News Sentiment Rating

0.42 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/4/2026
  • 3 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
5/4/2026
  • 2 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/3/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/3/2026
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/2/2026
  • 2 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/1/2026
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/1/2026
  • 2 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/31/2026

Current Sentiment

  • 2 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

SBC Medical Group logo
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO.
Read More

Today's Range

Now: $5.28
Low: $5.24
High: $5.70

50 Day Range

MA: $4.87
Low: $4.00
High: $5.69

52 Week Range

Now: $5.28
Low: $2.78
High: $5.79

Volume

155,292 shs

Average Volume

191,175 shs

Market Capitalization

$543.05 million

P/E Ratio

11.22

Dividend Yield

N/A

Beta

0.56

Frequently Asked Questions

What sell-side analysts currently cover shares of SBC Medical Group?

The following Wall Street sell-side analysts have issued research reports on SBC Medical Group in the last twelve months: BTIG Research, Maxim Group, Wall Street Zen, and Weiss Ratings.
View the latest analyst ratings for SBC.

What is the current price target for SBC Medical Group?

0 Wall Street analysts have set twelve-month price targets for SBC Medical Group in the last year. Their average twelve-month price target is $8.50, suggesting a possible upside of 61.0%. Maxim Group has the highest price target set, predicting SBC will reach $9.00 in the next twelve months. BTIG Research has the lowest price target set, forecasting a price of $8.00 for SBC Medical Group in the next year.
View the latest price targets for SBC.

What is the current consensus analyst rating for SBC Medical Group?

SBC Medical Group currently has 1 hold rating and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for SBC.

What other companies compete with SBC Medical Group?

Other companies that are similar to SBC Medical Group include Progyny, Astrana Health, Guardian Pharmacy Services, GeneDx and AMN Healthcare Services. Learn More about companies similar to SBC Medical Group.

How do I contact SBC Medical Group's investor relations team?

SBC Medical Group's physical mailing address is 200 Spectrum Center DR., Suite 300, Irvine, CA, 92618. The company's listed phone number is (949) 593-0250 and its investor relations email address is [email protected]. The official website for SBC Medical Group is sbc-holdings.com. Learn More about contacing SBC Medical Group investor relations.